Search This Blog

Thursday, July 30, 2020

NovoCure EPS beats by $0.02, beats on revenue

NovoCure (NASDAQ:NVCR): Q2 GAAP EPS of $0.02 beats by $0.02.
Revenue of $115.93M (+33.7% Y/Y) beats by $9.97M.
There were 3,278 active patients at June 30, representing 20% growth Y/Y.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)